These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 5096513)

  • 1. Relationship of nervous tissue transketolase to the neuropathy in chronic uremia.
    Sterzel RB; Semar M; Lonergan ET; Treser G; Lange K
    J Clin Invest; 1971 Nov; 50(11):2295-304. PubMed ID: 5096513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transketolase inhibition as a mechanism in uremic neuropathy.
    Lange K; Lonergan ET; Semar M; Sterzel RB
    Trans Assoc Am Physicians; 1971; 84():172-81. PubMed ID: 5164301
    [No Abstract]   [Full Text] [Related]  

  • 3. The uremic toxin oxythiamine causes functional thiamine deficiency in end-stage renal disease by inhibiting transketolase activity.
    Zhang F; Masania J; Anwar A; Xue M; Zehnder D; Kanji H; Rabbani N; Thornalley PJ
    Kidney Int; 2016 Aug; 90(2):396-403. PubMed ID: 27198804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte transketolase activity in uremia.
    Kuriyama M; Mizuma A; Yokomine R; Igata A; Otuji Y
    Clin Chim Acta; 1980 Dec; 108(2):169-77. PubMed ID: 6256098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transketolase and myelin.
    Collins RC; Lonergan ET
    N Engl J Med; 1971 Sep; 285(13):751-2. PubMed ID: 4398337
    [No Abstract]   [Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transketolase inhibition and uremic peripheral sensory neuropathy.
    Egan JD; Wells IC
    J Neurol Sci; 1979 May; 41(3):379-95. PubMed ID: 220393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hemodialysis on the inhibition of nervous tissue transketolase and on uremic neuropathy.
    Sterzel RB; Semar M; Lonergan ET; Lange K
    Trans Am Soc Artif Intern Organs; 1971; 17():77-9. PubMed ID: 5158138
    [No Abstract]   [Full Text] [Related]  

  • 9. THE REGIONAL DISTRIBUTION OF TRANSKETOLASE IN THE NORMAL AND THE THIAMINE DEFICIENT NERVOUS SYSTEM.
    DREYFUS PM
    J Neuropathol Exp Neurol; 1965 Jan; 24():119-29. PubMed ID: 14253567
    [No Abstract]   [Full Text] [Related]  

  • 10. Uremic neuropathy. Monitoring of transketolase activity inhibition in a child.
    McVicar M; Gauthier B; Goodman CT
    Am J Dis Child; 1973 Feb; 125(2):263-5. PubMed ID: 4265477
    [No Abstract]   [Full Text] [Related]  

  • 11. Encephalopathy of thiamine deficieny: studies of intracerebral mechanisms.
    McCandless DW; Schenker S; Cook M
    J Clin Invest; 1968 Oct; 47(10):2268-80. PubMed ID: 5676522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transketolase activity in uremia.
    Lonergan ET; Semar M; Lange K
    Arch Intern Med; 1970 Nov; 126(5):851-4. PubMed ID: 5475709
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythrocyte transketolase activity in dialyzed patients. A reversible metabolic lesion of uremia.
    Lonergan ET; Semar M; Sterzel RB; Treser G; Needle MA; Voyles L; Lange K
    N Engl J Med; 1971 Jun; 284(25):1399-403. PubMed ID: 4325316
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of ribose-5-phosphate in hemolysates. III. Quantitative determination of sedoheptulose-7-phosphate and some properties of the transketolase of erythrocytes and blood serum.
    BRUNS FH; DUNWALD E; NOLTMANN E
    Biochem Z; 1958; 330(6):497-508. PubMed ID: 13596392
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the thiamine nutritional state of uremic patients by determination of erythrocyte transketolase activity].
    Rizzo SC; Varasi C
    Minerva Nefrol; 1969; 16(4):301-5. PubMed ID: 5397050
    [No Abstract]   [Full Text] [Related]  

  • 16. [Non-uremic neuropathy in hemodialysis patients].
    Kondo H; Takeuchi M; Yatabe K; Mochizuki A; Iwata M
    No To Shinkei; 1997 Aug; 49(8):737-43. PubMed ID: 9282368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte transketolase activity in patients with diabetic and alcoholic neuropathies.
    Michalak S; Michałowska-Wender G; Adamcewicz G; Wender MB
    Folia Neuropathol; 2013; 51(3):222-6. PubMed ID: 24114639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate inhibition of transketolase.
    Solovjeva ON; Kovina MV; Kochetov GA
    Biochim Biophys Acta; 2016 Mar; 1864(3):280-282. PubMed ID: 26708478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of transketolase activity in blood].
    Hoffmann I; Knapp A; Rietz K; Milner C
    Clin Chim Acta; 1971 Jul; 33(2):415-21. PubMed ID: 5119318
    [No Abstract]   [Full Text] [Related]  

  • 20. A transketolase assembly defect in a Wernicke-Korsakoff syndrome patient.
    Wang JJ; Martin PR; Singleton CK
    Alcohol Clin Exp Res; 1997 Jun; 21(4):576-80. PubMed ID: 9194907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.